Meinir Krishnasamy1, Winnie Kwok-Wei So, Patsy Yates, Luz Esperanza Ayala de Calvo, Rachid Annab, Tami Wisniewski, Sanchia Aranda. 1. Author Affiliations: Peter MacCallum Cancer Centre and Faculty of Medicine, Dentistry, and Health Sciences, The University of Melbourne, Victoria, Australia (Drs Krishnasamy and Aranda and Mr Annab); Nethersole School of Nursing, Chinese University of Hong Kong, China (Dr Kwok-wei So); School of Nursing and Midwifery, Queensland University of Technology, Queensland, Australia (Dr Yates); School of Nursing, Pontificia Universidad Javeriana, Bogota, Colombia (Ms de Calvo); Merck & Co Inc, Whitehouse Station, New Jersey (Ms Wisniewski); Cancer Institute New South Wales, Sydney, Australia (Professor Aranda).
Abstract
BACKGROUND: Nurses play a substantial role in the prevention and management of chemotherapy-induced nausea and vomiting (CINV). OBJECTIVES: This study set out to describe nurses' roles in the prevention and management of CINV and to identify any gaps that exist across countries. METHODS: A self-reported survey was completed by 458 registered nurses who administered chemotherapy to cancer patients in Australia, China, Hong Kong, and 9 Latin American countries. RESULTS: More than one-third of participants regarded their own knowledge of CINV as fair to poor. Most participants (>65%) agreed that chemotherapy-induced nausea and chemotherapy-induced vomiting should be considered separately (79%), but only 35% were confident in their ability to manage chemotherapy-induced nausea (53%) or chemotherapy-induced vomiting (59%). Only one-fifth reported frequent use of a standardized CINV assessment tool and only a quarter used international clinical guidelines to manage CINV. CONCLUSIONS: Participants perceived their own knowledge of CINV management to be insufficient. They recognized the need to develop and use a standardized CINV assessment tool and the importance of adopting international guidelines to inform the management of CINV. IMPLICATIONS FOR PRACTICE: Findings indicate that international guidelines should be made available to nurses in clinically relevant and easily accessible formats, that a review of chemotherapy assessment tools should be undertaken to identify reliable and valid measures amenable to use in a clinical settings, and that a CINV risk screening tool should be developed as a prompt for nurses to enable timely identification of and intervention for patients at high risk of CINV.
BACKGROUND: Nurses play a substantial role in the prevention and management of chemotherapy-induced nausea and vomiting (CINV). OBJECTIVES: This study set out to describe nurses' roles in the prevention and management of CINV and to identify any gaps that exist across countries. METHODS: A self-reported survey was completed by 458 registered nurses who administered chemotherapy to cancerpatients in Australia, China, Hong Kong, and 9 Latin American countries. RESULTS: More than one-third of participants regarded their own knowledge of CINV as fair to poor. Most participants (>65%) agreed that chemotherapy-induced nausea and chemotherapy-induced vomiting should be considered separately (79%), but only 35% were confident in their ability to manage chemotherapy-induced nausea (53%) or chemotherapy-induced vomiting (59%). Only one-fifth reported frequent use of a standardized CINV assessment tool and only a quarter used international clinical guidelines to manage CINV. CONCLUSIONS:Participants perceived their own knowledge of CINV management to be insufficient. They recognized the need to develop and use a standardized CINV assessment tool and the importance of adopting international guidelines to inform the management of CINV. IMPLICATIONS FOR PRACTICE: Findings indicate that international guidelines should be made available to nurses in clinically relevant and easily accessible formats, that a review of chemotherapy assessment tools should be undertaken to identify reliable and valid measures amenable to use in a clinical settings, and that a CINV risk screening tool should be developed as a prompt for nurses to enable timely identification of and intervention for patients at high risk of CINV.
Authors: Anna Enblom; Gunnar Steineck; Mats Hammar; Sussanne Börjeson Journal: Evid Based Complement Alternat Med Date: 2017-02-08 Impact factor: 2.629
Authors: Robert S Epstein; Upal K Basu Roy; Matti Aapro; Tehseen Salimi; Donald Moran; JoAnn Krenitsky; Megan L Leone-Perkins; Cynthia Girman; Courtney Schlusser; Jeffrey Crawford Journal: Patient Prefer Adherence Date: 2021-02-25 Impact factor: 2.711